Nothing Special   »   [go: up one dir, main page]

SK285032B6 - Dávkovacie formy ibuprofénu - Google Patents

Dávkovacie formy ibuprofénu Download PDF

Info

Publication number
SK285032B6
SK285032B6 SK1142-98A SK114298A SK285032B6 SK 285032 B6 SK285032 B6 SK 285032B6 SK 114298 A SK114298 A SK 114298A SK 285032 B6 SK285032 B6 SK 285032B6
Authority
SK
Slovakia
Prior art keywords
ibuprofen
dosage form
sodium
bicarbonate
alkali metal
Prior art date
Application number
SK1142-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK114298A3 (en
Inventor
Ian Ashley Price
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of SK114298A3 publication Critical patent/SK114298A3/sk
Publication of SK285032B6 publication Critical patent/SK285032B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1142-98A 1996-02-21 1997-02-19 Dávkovacie formy ibuprofénu SK285032B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition
PCT/EP1997/000841 WO1997030699A2 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen

Publications (2)

Publication Number Publication Date
SK114298A3 SK114298A3 (en) 1999-01-11
SK285032B6 true SK285032B6 (sk) 2006-05-04

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1142-98A SK285032B6 (sk) 1996-02-21 1997-02-19 Dávkovacie formy ibuprofénu

Country Status (25)

Country Link
US (1) US20020034540A1 (de)
EP (1) EP0881899B1 (de)
JP (2) JP2000507922A (de)
KR (1) KR19990087084A (de)
CN (1) CN1215989A (de)
AT (1) ATE273696T1 (de)
AU (1) AU722991B2 (de)
BG (1) BG64165B1 (de)
CA (1) CA2246344C (de)
CZ (1) CZ298371B6 (de)
DE (1) DE69730314T2 (de)
DK (1) DK0881899T3 (de)
ES (1) ES2227670T3 (de)
GB (1) GB9603699D0 (de)
HU (1) HUP9901454A3 (de)
IL (1) IL125803A0 (de)
NO (1) NO983825L (de)
NZ (1) NZ331416A (de)
PL (1) PL187383B1 (de)
PT (1) PT881899E (de)
RU (1) RU2182000C2 (de)
SK (1) SK285032B6 (de)
UA (1) UA55407C2 (de)
WO (1) WO1997030699A2 (de)
ZA (1) ZA971446B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
WO2002083105A2 (en) * 2001-04-10 2002-10-24 Zagros Pharma Inc. Composition for enhanced absorption of nsaids
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
CA2510320C (en) * 2002-12-20 2012-10-09 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
PE20050445A1 (es) * 2003-10-30 2005-06-18 Bayer Consumer Care Ag Forma de presentacion del naproxeno sodico
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
AU2005247048B2 (en) * 2004-05-28 2007-12-13 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CN1976678B (zh) * 2004-06-29 2010-06-02 奈康明丹麦有限责任公司 水不溶性药快速释放药物组合物的制造方法及通过本方法得到的药物组合物
CN102784113A (zh) * 2004-08-12 2012-11-21 利洁时保健（英国）有限公司 用熔融挤出法制备并含有对乙酰氨基酚、非甾体抗炎药物和糖醇的颗粒剂
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
EP1817021A1 (de) * 2004-11-03 2007-08-15 Equitech Corporation Nsaid-zusammensetzungen mit klinischer qualität
SI1850834T1 (sl) * 2005-02-09 2014-12-31 Boehringer Ingelheim International Gmbh Filmsko obloĹľene tablete, ki vsebujejo ibuprofen lizinat
EP1800667A1 (de) 2005-12-23 2007-06-27 Losan Pharma GmbH Schnell lösliches Ibuprofen-Granulat
EP1863460B1 (de) 2005-03-22 2013-01-16 Losan Pharma GmbH Gelöstes ibuprofen
EP1926481A2 (de) * 2005-09-19 2008-06-04 Albermarle Corporation Hochkonzentrierte giessbare wässrige lösungen von kalium-ibuprofen, ihre herstellung und verwendung
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
MX2009006823A (es) * 2006-12-20 2009-07-03 Duramed Pharmaceuticals Inc Formas de dosificacion solidas de desintegracion oral que comprenden progestina y metodos para hacer y usar las mismas.
CA2723409C (en) * 2008-05-09 2016-11-08 Atacama Labs Oy Method and apparatus for dry granulation
WO2010011522A1 (en) 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US20110144207A1 (en) * 2008-08-14 2011-06-16 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
PT2445486T (pt) * 2009-06-22 2018-01-03 Wyeth Llc Comprimidos de ibuprofeno de sódio e métodos de fabrico de composições farmacêuticas que incluem ibuprofeno de sódio
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
KR101890649B1 (ko) * 2013-07-30 2018-09-28 라이온 가부시키가이샤 정제
EP2845850A1 (de) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidinderivate als Oxytocin/Vasopressin-V1a-Rezeptorantagonisten
EP2886107A1 (de) * 2013-12-17 2015-06-24 ObsEva S.A. Orale Formulierungen von Pyrrolydinderivaten
CN106795110A (zh) 2014-07-02 2017-05-31 奥布赛瓦股份公司 治疗ot‑r活性相关的病症的方法中可用的晶体(3z，5s)‑5‑(羟甲基)‑1‑[(2’‑甲基‑1，1’‑联苯‑4‑基)羰基]吡咯烷‑3‑酮o‑甲基肟
EP2965746B1 (de) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. Orale pharmazeutische Zusammensetzung mit Ibuprofen, Ibuprofennatriumdihydrat, Pseudoephedrinhydrochlorid und Chlorpheniraminmaleat
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
AU658415B2 (en) * 1991-05-13 1995-04-13 Boots Company Plc, The Pharmaceutical composition comprising ibuprofen salt
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
ES2134796T3 (es) * 1992-12-01 1999-10-16 Spirig Ag Pharmazeutische Prap Composiciones farmaceuticas que contienen s(+)-ibuprofeno.

Also Published As

Publication number Publication date
ATE273696T1 (de) 2004-09-15
RU2182000C2 (ru) 2002-05-10
WO1997030699A3 (en) 1997-10-09
DE69730314T2 (de) 2005-08-18
PL187383B1 (pl) 2004-06-30
DK0881899T3 (da) 2004-12-20
PT881899E (pt) 2004-12-31
NO983825D0 (no) 1998-08-20
US20020034540A1 (en) 2002-03-21
CZ298371B6 (cs) 2007-09-12
SK114298A3 (en) 1999-01-11
CA2246344A1 (en) 1997-08-28
CZ261798A3 (cs) 1998-11-11
NZ331416A (en) 2000-02-28
IL125803A0 (en) 1999-04-11
NO983825L (no) 1998-10-20
EP0881899A2 (de) 1998-12-09
HUP9901454A2 (hu) 1999-08-30
JP2009073847A (ja) 2009-04-09
UA55407C2 (uk) 2003-04-15
EP0881899B1 (de) 2004-08-18
BG64165B1 (bg) 2004-03-31
KR19990087084A (ko) 1999-12-15
ZA971446B (en) 1997-11-25
AU722991B2 (en) 2000-08-17
DE69730314D1 (de) 2004-09-23
HUP9901454A3 (en) 2001-04-28
CA2246344C (en) 2009-01-20
CN1215989A (zh) 1999-05-05
BG102744A (en) 1999-05-31
GB9603699D0 (en) 1996-04-17
WO1997030699A2 (en) 1997-08-28
JP2000507922A (ja) 2000-06-27
AU1793797A (en) 1997-09-10
PL328465A1 (en) 1999-02-01
ES2227670T3 (es) 2005-04-01

Similar Documents

Publication Publication Date Title
SK285032B6 (sk) Dávkovacie formy ibuprofénu
JP2009073847A6 (ja) イブプロフェンの剤型
JP6092936B2 (ja) 口腔内崩壊錠の製造方法
US20030008003A1 (en) Compositions for enhanced absorption of NSAIDs
JPH1017497A (ja) 徐放性製剤およびその製造方法
TW202227066A (zh) 為錠劑形式之含奧美拉唑、埃索美拉唑或其醫藥上可接受鹽之醫藥組成物及其製備程序
JP5362556B2 (ja) アリスキレンおよびヒドロクロロチアジドのガレヌス製剤
EP1100472B1 (de) Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungen
US20050249808A1 (en) NSAIDs compositions containing tartaric acid
JP2006335771A (ja) 徐放性製剤およびその製造方法
EP3886817A1 (de) Pharmazeutische zusammensetzung mit ramipril und indapamid
CA2589079A1 (en) Nsaid compositions exhibiting clinical superiority
JP6328138B2 (ja) Ｎ−［５−［２−（３，５−ジメトキシフェニル）エチル］−２ｈ−ピラゾール−３−イル］−４−［（３ｒ，５ｓ）−３，５−ジメチルピペラジン−１−イル］ベンズアミドの医薬製剤
EP0975337B1 (de) Schnellfreisetzende komprimierte flurbiprofen enthaltende tablette
US20080081069A1 (en) Novel controlled release formulations of divalproex sodium
MXPA98006688A (en) Dosage form of ibuprophene
JP2005015371A (ja) プソイドエフェドリン類含有徐放性固形製剤